Variant Synonymizer: Platform to identify mutations defined in different ways is available now!
Over 2,000 gene–disease validation summaries are now available—no login required!
FAM20A deficiency causes an autosomal recessive enamel-renal syndrome (amelogenesis imperfecta type IG, ERS) characterized by severe hypoplastic enamel, gingival hyperplasia, and nephrocalcinosis presenting in early childhood. Affected individuals exhibit failed or delayed tooth eruption, intra-pulpal calcifications, and variable renal calcifications requiring long-term monitoring.
Genetic evidence comprises at least 69 probands across over 50 unrelated families, with consanguineous pedigrees and homozygous or compound heterozygous loss-of-function variants disrupting FAM20A ([PMID:33994680]). Case reports document recurrent frameshift and nonsense variants leading to protein truncation and nonsense-mediated decay.
Segregation analysis reveals 30 additional affected relatives in multiplex families, confirming autosomal recessive inheritance and variant pathogenicity ([PMID:33994680]). The variant spectrum is dominated by frameshift alleles such as c.734_735delAG (p.Glu245GlyfsTer11) ([PMID:31131889]) and a Brazilian founder c.1447del (p.Glu483LysfsTer24) ([PMID:30394349]), with a smaller number of missense changes affecting the kinase-like domain.
Functional studies demonstrate that FAM20A is a secretory pathway pseudokinase essential for activation and extracellular secretion of FAM20C. Fam20a null mice exhibit ectopic renal calcifications and enamel defects analogous to human ERS ([PMID:23468644]), and co-expression assays show loss of extracellular FAM20C in Fam20a-deficient cells ([PMID:27292199]).
Structural analyses reveal FAM20A binds ATP in an inverted orientation and forms dimers critical for allosteric activation of FAM20C, elucidating a loss-of-function mechanism through impaired kinase complex formation ([PMID:28432788]).
Cumulatively, the robust genetic and experimental evidence supports a Definitive FAM20A–ERS gene-disease association. Biallelic FAM20A loss-of-function variants should be included in genetic diagnostic panels for amelogenesis imperfecta to guide multidisciplinary management and renal surveillance. Key Take-home: early molecular diagnosis of FAM20A-related ERS enables targeted dental rehabilitation and prevention of renal complications.
Gene–Disease AssociationDefinitive
Genetic EvidenceStrongBiallelic LoF variants in >69 individuals across consanguineous pedigrees, segregation in 30 relatives Functional EvidenceStrongFam20a null mice replicate renal and dental phenotypes; in vitro assays show disrupted FAM20C activation and structural analyses confirming loss-of-function mechanism |